-
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Sunday, July 24, 2016 - 4:03pm | 873Read More...Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...
-
Edwards Lifesciences Gains 8% Following Positive Trial
Monday, April 4, 2016 - 7:36am | 280Read More...Shares of Edwards Lifesciences Corp (NYSE: EW) gained more than 8 percent early Monday morning after the company announced over the weekend results from a clinical study involving patients at intermediate risk for open-heart surgery. Edwards Lifesciences stated its data showed that patients at...
-
Market Wrap For May 21: Fed's Minutes Support Wednesday's Bull Run
Wednesday, May 21, 2014 - 4:37pm | 2652Read More...U.S. stocks rose at the opening bell and continued to rise throughout the trading session. Investors and traders breathed a sigh of relief when the Federal Reserve indicated a rate hike is not likely in the short term. According to the Fed, it is examining multiple strategies to tighten its...
-
Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive
Tuesday, April 22, 2014 - 4:52pm | 2838Read More...U.S. stocks rose as investors cheered recent earning reports and a positive home sales data for March. A $45 billion M&A offer also contributed to Tuesday's buying action as investors could be excited and motivated to buy stocks ahead of a few rough weeks of bearish activity. The S&P...
-
Market Wrap For April 15: Who Doesn't Love A Turnaround?
Tuesday, April 15, 2014 - 4:30pm | 2505Read More...U.S. stock futures were pointing towards a modestly higher open as investors found enough optimism from Dow components Coca-Cola and Johnson & Johnson who both reported better than expected quarterly results. Investors were further spooked by reports of pro-Russian separatists taking...
-
Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings
Monday, April 14, 2014 - 4:36pm | 2450Read More...U.S. stocks rose to start off the holiday-filled shortened trading week on a positive note as investors found plenty of reason to be optimistic on retail sales which jumped the most since 2012. Investors were also encouraged by Citigroup's better than expected earnings which eased investor...
-
Market Wrap For December 9: Investors Digest Further Clues Hinting at An Upcoming Taper
Monday, December 9, 2013 - 5:45pm | 1739Read More...According to Jim Bullard, the chances of the Fed tapering have increased due to recent labor market data. “There is no widely accepted reason why inflation is running as low as it is in the face of extraordinarily accommodative policy for the Fed,” he added. The St. Louis Fed chief added that...
-
Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying
Tuesday, June 26, 2012 - 10:13am | 1074Read More...Insiders may buy shares of a company because they believe its stock price will move higher and want to profit from this anticipated rise. Sell-offs might provide an opportunity for insiders who have faith in a company to snatch up shares. Below are some stocks that have recently seen insider buying...
-
Morgan Keenan Upgrades Edwards Lifesciences from Market Perform to Outperform
Monday, July 25, 2011 - 8:42amRead More... -
Morgan Stanley Gives Color on Edwards Lifesciences After SAPIEN FDA Panel
Monday, July 25, 2011 - 6:46am | 139Read More...Morgan Stanley has published a report on Edwards Lifesciences (NYSE: EW). In the report, Morgan Stanley wrote, "The SAPIEN FDA panel was in line with the expectations we set forth heading into the meeting, but clearly the consensus debate narrowed rapidly and has pressured EW shares. In this note...
-
Piper Jaffray Reiterates Overweight on Edwards Lifesciences
Thursday, June 9, 2011 - 7:22am | 124Read More...Piper Jaffray reiterated its Overweight rating on Edwards Lifesciences (NYSE: EW) after attending the Transcatheter Valve Therapies meeting. In a research report published today, Piper Jaffray states, "We expect FDA approval of EW's transcatheter valve system yet this year (mid-October is our...
-
Bank of America Merrill Lynch Maintains Neutral on Edwards Lifesciences
Monday, June 6, 2011 - 9:09am | 132Read More...Bank of America Merrill Lynch is out with its report today on Edwards Lifesciences (NYSE: EW), maintaining Neutral. In a note to clients, Bank of America Merrill Lynch writes, "Over the next five-plus years, there is no other new product opportunity in medtech of a similar potential size as the...
-
Morgan Stanley Comments on Edwards Lifesciences
Wednesday, May 18, 2011 - 8:12am | 124Read More...Morgan Stanley commented on Edwards Lifesciences (NYSE: EW). In a research report published today, Morgan Stanley stressed that a number of research had worrying implications for transapical implants. In the report, Morgan Stanley states, "While neither the analyses presented today at PCR nor the...
-
Wedbush Reports Solid Q1 Results For Edwards Lifesciences
Thursday, April 21, 2011 - 10:19am | 123Read More...According to Wedbush, Edwards Lifesciences (NYSE: EW) saw solid Q1 2011 results that beat expectations. Wedbush said that EW reports Q1:2011 revenues of $404.5MM and EPS of $0.53, compared to estimates of $392.0MM and $0.42 and consensus of $384.1 million and $0.42. “EW reported very strong Q1:11...
-
Wedbush Upgrades Edwards Lifesciences To Neutral, PT To $78
Thursday, April 21, 2011 - 9:01am | 28Read More...Wedbush Securities has upgraded Edwards Lifesciences (NYSE: EW) from Underperform to Neutral and has raised the price target from $75 to $78.
